PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans.
Journal
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
15
01
2021
accepted:
09
03
2021
revised:
09
03
2021
pubmed:
26
3
2021
medline:
27
1
2022
entrez:
25
3
2021
Statut:
ppublish
Résumé
Dermatofibrosarcoma protuberans (DFSP) is a spindle cell neoplasm of the skin and superficial soft tissue with a tendency for locally aggressive behavior; metastatic potential coincides with fibrosarcomatous transformation. The vast majority of DFSPs harbor the t(17;22) translocation resulting in a COL1A1-PDGFB fusion that drives autocrine growth stimulation via PDGFB overexpression. Here, we examined the utility of PDGFB RNA chromogenic in situ hybridization (CISH) for the diagnosis of DFSP. A total of 337 tumors represented in whole tissue sections and tissue microarrays, including 37 cases of DFSP and 300 histologically similar spindle cell tumors, were subjected to PDGFB RNA CISH using commercially available probes. PDGFB overexpression was observed by light microscopy in 24 of 26 conventional DFSPs (92%) and 11 of 11 fibrosarcomatous DFSPs (100%). One of two DFSPs negative for PDGFB by RNA CISH was found to harbor an uncommon alternative rearrangement involving PDGFD. All examined cases of histologic mimics were negative for PDGFB overexpression; limited PDGFB expression, not reaching an empirical threshold of greater than 5 puncta or one aggregate of chromogen in more than 25% of cells, was observed in 7 of 300 mimics (2.3%), including desmoplastic melanoma, malignant peripheral nerve sheath tumor, angiosarcoma, and pleomorphic dermal sarcoma. Vascular PDGFB expression was seen in several tumor types. We conclude that PDGFB RNA CISH, with careful interpretation and the use of appropriate thresholds, may serve as a surrogate marker of PDGFB rearrangement and a useful ancillary tool for the diagnosis of DFSP.
Identifiants
pubmed: 33762682
doi: 10.1038/s41379-021-00800-2
pii: S0893-3952(22)00566-X
pmc: PMC8298273
mid: NIHMS1686868
doi:
Substances chimiques
Biomarkers, Tumor
0
Proto-Oncogene Proteins c-sis
0
RNA
63231-63-0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1521-1529Subventions
Organisme : NCATS NIH HHS
ID : KL2 TR003143
Pays : United States
Informations de copyright
© 2021. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.
Références
Genes Chromosomes Cancer. 2003 May;37(1):1-19
pubmed: 12661001
Mod Pathol. 2006 Nov;19(11):1512-8
pubmed: 16980946
Mod Pathol. 2014 Mar;27(3):390-5
pubmed: 24030747
Pathology. 2014 Aug;46(5):389-95
pubmed: 24977739
J Cutan Pathol. 1996 Feb;23(1):30-6
pubmed: 8720984
Am J Dermatopathol. 1993 Oct;15(5):429-34
pubmed: 7694515
Am J Surg Pathol. 2020 Dec;44(12):1581-1590
pubmed: 32826531
Am J Surg Pathol. 2007 Sep;31(9):1371-7
pubmed: 17721193
Am J Surg Pathol. 2014 Apr;38(4):552-9
pubmed: 24625420
Nat Med. 1998 Jul;4(7):844-7
pubmed: 9662379
Mod Pathol. 2007 Jun;20(6):668-75
pubmed: 17431412
Am J Surg Pathol. 2021 Apr 1;45(4):488-497
pubmed: 33165092
Am J Surg Pathol. 2021 Feb 1;45(2):230-239
pubmed: 32815829
Am J Surg Pathol. 2000 Aug;24(8):1125-30
pubmed: 10935653
Am J Surg Pathol. 2019 Apr;43(4):446-454
pubmed: 30520819
Am J Dermatopathol. 1997 Apr;19(2):147-53
pubmed: 9129699
Am J Surg Pathol. 1985 Sep;9(9):630-9
pubmed: 3901787
Am J Surg Pathol. 2016 Jan;40(1):94-102
pubmed: 26414223
Am J Surg Pathol. 1998 May;22(5):576-87
pubmed: 9591728
Cancer. 2000 Jun 15;88(12):2711-20
pubmed: 10870053
Blood. 2016 Jun 16;127(24):3004-14
pubmed: 26966091
Hum Pathol. 2008 Feb;39(2):184-93
pubmed: 17950782
Histopathology. 2019 Jan;74(2):332-340
pubmed: 30152874
Mod Pathol. 2015 Feb;28(2):230-7
pubmed: 25081750
Genes Chromosomes Cancer. 2018 Sep;57(9):437-445
pubmed: 30014607
Hum Pathol. 2011 Feb;42(2):176-84
pubmed: 21111450
Mod Pathol. 2018 Nov;31(11):1683-1693
pubmed: 29955147
Histopathology. 2015 Dec;67(6):827-35
pubmed: 25879300
Genes Dev. 2008 May 15;22(10):1276-312
pubmed: 18483217